APPH Limited:企業の戦略・SWOT・財務情報

◆英語タイトル:APPH Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C5705
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:航空・防衛
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

APPH Limited – Strategy, SWOT and Corporate Finance Report
Summary

APPH Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

APPH Limited (APPH) designs and manufactures complete landing gear systems and hydraulic systems for the commercial and military aircraft. The company offers development, testing, certification, manufacturing, machining, repair and overhaul, and aircraft-on-ground (AOG) support services. The company’s hydraulic systems, landing gear, and filtration systems and subsystems are used for business jets, civilian airlines, military helicopters and advanced fighter jets. APPH also manufactures complex, multi-axis and mill-turn machined components for landing gears, match-ground hydraulic flight controls, and aero-engine casings. Its major customers include Airbus, Boeing, Embraer, Raytheon, Rolls-Royce, Sikorsky and Vickers. The company operates as a subsidiary of Heroux-Devtek Inc. APPH is headquartered in Runcorn, England, the UK.

Scope

- Detailed information on APPH Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting APPH Limited in the form of a SWOT analysis
- An in-depth view of the business model of APPH Limited including a breakdown and examination of key business segments
- Intelligence on APPH Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about APPH Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of APPH Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess APPH Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on APPH Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
APPH Limited: Company Overview 7
APPH Limited: Overview and Key Facts 7
APPH Limited: Overview 7
APPH Limited: Key Facts 7
APPH Limited: Key Employees 8
APPH Limited: Major Products and Services 9
APPH Limited: Company History 10
APPH Limited: Key Competitors 11
APPH Limited: Company Analysis 12
APPH Limited: Business Description 12
APPH Limited: SWOT Analysis 13
APPH Limited: SWOT Overview 13
APPH Limited: Strengths 13
APPH Limited: Weaknesses 14
APPH Limited: Opportunities 14
APPH Limited: Threats 15
APPH Limited: Corporate Financial Deals Activity 16
APPH Limited: Financial Deals Overview 16
APPH Limited: Top Deals 2014 – 2018YTD* 17
APPH Limited: Private Equity and Ownership 18
Appendix 19
Contact Us 19
Methodology 19
About MarketLine 20

List of Tables
Table 1: APPH Limited: Key Facts
Table 2: APPH Limited: Key Employees
Table 3: APPH Limited: Company History
Table 4: APPH Limited: Key Competitors
Table 5: APPH Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: APPH Limited: Top Deals 2014 - 2018YTD*
Table 7: APPH Limited: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 8: APPH Limited: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

List of Figures
Figure 1: APPH Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: APPH Limited: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 3: APPH Limited: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[APPH Limited:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Al-Nisr Al Arabi Insurance Company:企業の戦略・SWOT・財務情報
    Al-Nisr Al Arabi Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Al-Nisr Al Arabi Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Main Street America Group Inc:企業の戦略的SWOT分析
    Main Street America Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Petroliam Nasional Berhad:企業の戦略・SWOT・財務情報
    Petroliam Nasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Petroliam Nasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Lonza Group Ltd (LONN):製薬・医療:M&Aディール及び事業提携情報
    Summary Lonza Group Ltd (Lonza) is a biopharmaceutical company that manufactures and develops chemical and biological active pharmaceutical ingredients, and other products and services. The company offers active pharmaceutical ingredients, stem cell therapies, drinking water sanitizers, vitamin B co …
  • Brii Biosciences:製薬・医療:M&Aディール及び事業提携情報
    Summary Brii Biosciences is an independent biotechnology company that focuses on developing and commercializing innovative medicines for infectious diseases, liver and lung diseases, and other chronic diseases. The company strives to advance breakthroughs in science and technology, and enable patien …
  • Biofrontera AG (B8F):医療機器:M&Aディール及び事業提携情報
    Summary Biofrontera AG (Biofrontera) is a biopharmaceutical company that develops and commercializes dermatological medications and medical cosmetics. The company’s products comprise Ameluz, BF-RhodoLED and Belixos. Its prescription drug Ameluz is used for the treatment of skin disease actinic kerat …
  • Husky Energy Inc (HSE)-石油・ガス分野:企業M&A・提携分析
    Summary Husky Energy Inc. (Husky) is an integrated oil and gas company. The company has operations in upstream and downstream sectors of oil and gas value chain. Its upstream operations include the exploration, development and production of crude oil, bitumen and natural gas. Husky also carried out …
  • The Kyoto Hotel, Ltd.:企業の戦略・SWOT・財務分析
    The Kyoto Hotel, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Kyoto Hotel, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SPX Corporation:企業の戦略・SWOT・財務情報
    SPX Corporation - Strategy, SWOT and Corporate Finance Report Summary SPX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Tav Havalimanlari Holding AS:戦略・SWOT・企業財務分析
    Tav Havalimanlari Holding AS - Strategy, SWOT and Corporate Finance Report Summary Tav Havalimanlari Holding AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Innate Pharma SA (IPH):企業の財務・戦略的SWOT分析
    Summary Innate Pharma SA (Innate Pharma) is a healthcare products provider that develops immunopharmacology and antibody technology products. The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclo …
  • Weight Watchers International, Inc.:企業の戦略・SWOT・財務分析
    Weight Watchers International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Weight Watchers International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Waste Management, Inc.:企業の戦略・SWOT・財務情報
    Waste Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Waste Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • E.ON SE:発電所・企業SWOT分析
    E.ON SE - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • United Continental Holdings Inc:戦略・SWOT・企業財務分析
    United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Intra-Cellular Therapies Inc (ITCI):企業の財務・戦略的SWOT分析
    Summary Intra-Cellular Therapies Inc (ITI) is a novel drug manufacturer. The company offers product platform such as ITCI Pipeline that includes lumateperone, ITI-007 platform, PDE inhibitor platform and drug discovery platform. The company’s lead product candidate ITI-007-lumateperone is to treat s …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-医療機器分野:企業M&A・提携分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Tamir Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Tamir Biotechnology Inc (Tamir Biotechnology), formerly Alfacell Corp is a clinical stage antiviral therapeutics company that discovers and develops prophylactic and therapeutic drugs for the treatment of viruses and other pathological conditions. The company’s targets include human papillom …
  • Dentsply Sirona, Inc.:企業の戦略・SWOT・財務分析
    Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Celsius Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Celsius Therapeutics Inc (Celsius Therapeutics) is a biotechnology company that carries out single-cell genomic analysis to discover and develop precision medicines for autoimmune diseases and cancer. The company’s drug discovery is based on understanding specific cells that play a major rol …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆